Given Trump's climate scepticism and passionate love of fossil fuels, it is safe to say that the renewables industry has a ...

Promising exosomes-based therapies in the pipeline in various stages of development include CAP-1002, Progenza, AGLE 102, ExoCoVac, COYA 201, EV-101, StemXO Endosome Therapy, BRE AD01, ILB 202, Zofin, ...

RBC Capital Markets says the business empire, controlled by retail tycoon Mike Ashley (pictured), has a strong core business ...

The 21st Global Water Drinks Congress was held in Frankfurt, Germany, from October 28th to 30th. During the Congress, ...

So you’ll often find that some of your favourite outdoor or sportswear brands - like Salomon, adidas, Saucony and more - work ...

In 1979, Audiovector’s founder, Ole Klifoth, launched his Trapez loudspeaker. It was the company’s first commercial speaker ...

What do warts, pap smears, cervical cancer, head and neck cancer, and a vaccine all have in common? Three letters: HPV ...

California-based Septerna is developing therapies targeting G-protein-coupled receptors (GPCR), a class of proteins that serve as a main conduit for chemicals to get past a cell's membrane and be ...

Small-cap exchange-traded funds can boost returns and improve diversification under the right circumstances. Still, recent results highlight that small-cap investing is not without risks and that ...

That's why Lori Keith, director of research and portfolio manager at Parnassus Investments, is such a big fan of mid-cap stocks. Keith oversees $3.2 billion of assets in the Parnassus Mid Cap Fund.